Approach to Decompensated Right Heart Failure in the Acute Setting

被引:5
作者
Levitt, Catherine V. [1 ]
Williams, Caitlin A. [1 ]
Ahari, Jalil [2 ]
Pourmand, Ali [1 ]
机构
[1] George Washington Univ, Sch Med & Hlth Sci, Dept Emergency Med, Washington, DC 20037 USA
[2] George Washington Univ, Pulm & Crit Care Med, Sch Med & Hlth Sci, Washington, DC 20037 USA
关键词
acute right heart failure; right ventricular failure; pulmonary vascular resistance; pulmonary arterial hypertension; RIGHT-VENTRICULAR FUNCTION; CARE-UNIT MANAGEMENT; PULMONARY-HYPERTENSION; EUROPEAN-SOCIETY; DOBUTAMINE; PATHOPHYSIOLOGY; LEVOSIMENDAN; ASSOCIATION; DYSFUNCTION; STATEMENT;
D O I
10.3390/jcm13030869
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute right heart failure (ARHF) arises when the right ventricle fails to pump blood efficiently to the pulmonary circulation. This inefficiency leads to a decreased blood supply to various organs. ARHF is a significant health concern, often leading to increased hospital admissions and being associated with a higher risk of mortality. This condition underscores the importance of effective cardiac care and timely intervention to manage its complications and improve patient outcomes. Diagnosing ARHF involves a comprehensive approach that includes a physical examination to evaluate the patient's fluid status and heart-lung function, blood tests to identify potential triggers and help forecast patient outcomes and various imaging techniques. These imaging techniques include electrocardiograms, point-of-care ultrasounds, computed tomography, cardiac magnetic resonance imaging, and other advanced monitoring methods. These diagnostic tools collectively aid in a detailed assessment of the patient's cardiac and pulmonary health, essential for effective management of ARHF. The management of ARHF focuses on addressing the underlying causes, regulating fluid balance, and enhancing cardiac function through pharmacological treatments or mechanical support aimed at boosting right heart performance. This management strategy includes the use of medications that modulate preload, afterload, and inotropy; vasopressors; anti-arrhythmic drugs; ensuring proper oxygenation and ventilation; and the utilization of heart and lung assist devices as a bridge to potential transplantation. This review article is dedicated to exploring the pathophysiology of ARHF, examining its associated morbidity and mortality, evaluating the various diagnostic tools available, and discussing the diverse treatment modalities. The article seeks to provide a comprehensive understanding of ARHF, its impact on health, and the current strategies for its management.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Prognostic Value of the Echocardiographic Probability of Pulmonary Hypertension in Patients with Acute Decompensated Heart Failure
    Carballo, Sebastian
    Musso, Philippe
    Garin, Nicolas
    Mueller, Hajo
    Serratrice, Jacques
    Mach, Francois
    Carballo, David
    Stirnemann, Jerome
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [32] Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms
    Fedele, Francesco
    Bruno, Noemi
    Brasolin, Bruno
    Caira, Carmen
    D'Ambrosi, Alessandra
    Mancone, Massimo
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (03) : 281 - 288
  • [34] Acute right heart failure in pulmonary hypertension
    Lange, T. J.
    Lubnow, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (40) : 2023 - 2026
  • [35] De Novo Acute Heart Failure and Acutely Decompensated Chronic Heart Failure
    Hummel, Astrid
    Empen, Klaus
    Doerr, Marcus
    Felix, Stephan B.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (17): : 298 - 309
  • [36] Right Ventricular Response to Intensive Medical Therapy in Advanced Decompensated Heart Failure
    Verhaert, David
    Mullens, Wilfried
    Borowski, Allen
    Popovic, Zoran B.
    Curtin, Ronan J.
    Thomas, James D.
    Tang, W. H. Wilson
    CIRCULATION-HEART FAILURE, 2010, 3 (03) : 340 - 346
  • [37] Management of right ventricular dysfunction in the perioperative setting
    Zarbock, Alexander
    Van Aken, Hugo
    Schmidt, Christoph
    CURRENT OPINION IN ANESTHESIOLOGY, 2014, 27 (04) : 388 - 393
  • [38] Acute Kidney Disease After Acute Decompensated Heart Failure
    Chen, Jia-Jin
    Lee, Tao-Han
    Kuo, George
    Yen, Chieh-Li
    Chen, Shao-Wei
    Chu, Pao-Hsien
    Fan, Pei-Chun
    Wu, Victor Chien-Chia
    Chang, Chih-Hsiang
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (03): : 526 - 536
  • [39] LevosimendanA Review of its Use in the Management of Acute Decompensated Heart Failure
    Carmen A. Innes
    Antona J. Wagstaff
    Drugs, 2003, 63 : 2651 - 2671
  • [40] Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
    Juguet, William
    Fard, Damien
    Faivre, Laureline
    Koutsoukis, Athanasios
    Deguillard, Camille
    Mongardon, Nicolas
    Mekontso-Dessap, Armand
    Huguet, Raphaelle
    Lim, Pascal
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 11